First Trust Nasdaq Pharmaceuticals ETF (FTXH) price, chart and fund profile

Price chart

Fund profile

FTXH tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth.

Issuer

First Trust Advisors L.P.

Industry

Healthcare

Inception

Sep 20, 2016

Assets under management

$1.1B

Expense ratio

0.60%

Net asset value

$40.38

NAV as of

Oct 13, 2026

Distributions

Quarterly

Leverage

1×

Fund page

www.ftportfolios.com↗

• What is First Trust Nasdaq Pharmaceuticals ETF (FTXH)?

  FTXH tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth.

• What is FTXH's expense ratio?

  First Trust Nasdaq Pharmaceuticals ETF charges an annual expense ratio of 0.60%. The fund is issued by First Trust Advisors L.P..

• How large is FTXH?

  First Trust Nasdaq Pharmaceuticals ETF manages $1.1B in assets and has traded since Sep 20, 2016.

• How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF (FTXH)?

  FTXH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.